Some sarcomas have specific molecular characteristics, such as SYT::SSX fusion in synovial sarcoma, EWSR1::FLI1 fusion in Ewing's sarcoma (ES), and MDM2 amplification in dedifferentiated liposarcoma (DDLS), leading to correct diagnosis and treatment [2]. This evidence concerns the gene FLI1 and synovial sarcoma.